| Wilson P Daugherty, MD, PH D | |
|
301 Riverview Ave Ste 202a, Norfolk, VA 23510-1065 | |
| (757) 252-9140 | |
| (757) 793-4149 |
| Full Name | Wilson P Daugherty |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 20 Years |
| Location | 301 Riverview Ave Ste 202a, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023094950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 2011-01173 (North Carolina) | Secondary |
| 207T00000X | Neurological Surgery | 0101259100 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-northeast | Concord, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Carolinas Medical Center-pineville | Charlotte, NC | Hospital |
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sentara Medical Group | 8921903923 | 1058 |
News Archive
Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.
A team of researchers from the National University of Singapore's (NUS) Yong Loo Lin School of Medicine has demonstrated for the first time that hydrogen sulphide (H2S), when applied exogenously, could protect testicular germ cells, which are male reproductive cells, against heat-induced injury, which is one of the major causes of male infertility.
The proteins that have now been identified shouldn't actually exist. Nevertheless, they build the core of cellular aggregates whose identity has been enigmatic until now. These aggregates are typically associated with hereditary neurodegenerative diseases including variants of frontotemporal dementia (FTD), also known as frontotemporal lobar degeneration (FTLD), and amyotrophic lateral sclerosis (ALS). They are likely to be damaging and might be a target for therapy.
A team of Chinese researchers have for the first time "mended" defective embryos using chemical surgery to free them of a faulty gene that leads to beta thalassemia. Until now this defect was found to be incorrigible caused due to a single misspelling in the DNA code. Beta thalassemia is a dreaded blood disorder wherein the child is unable to make healthy blood needing blood transfusions on a regular basis. The study was published this week in the journal Protein and Cell.
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.
› Verified 2 days ago
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.
A team of researchers from the National University of Singapore's (NUS) Yong Loo Lin School of Medicine has demonstrated for the first time that hydrogen sulphide (H2S), when applied exogenously, could protect testicular germ cells, which are male reproductive cells, against heat-induced injury, which is one of the major causes of male infertility.
The proteins that have now been identified shouldn't actually exist. Nevertheless, they build the core of cellular aggregates whose identity has been enigmatic until now. These aggregates are typically associated with hereditary neurodegenerative diseases including variants of frontotemporal dementia (FTD), also known as frontotemporal lobar degeneration (FTLD), and amyotrophic lateral sclerosis (ALS). They are likely to be damaging and might be a target for therapy.
A team of Chinese researchers have for the first time "mended" defective embryos using chemical surgery to free them of a faulty gene that leads to beta thalassemia. Until now this defect was found to be incorrigible caused due to a single misspelling in the DNA code. Beta thalassemia is a dreaded blood disorder wherein the child is unable to make healthy blood needing blood transfusions on a regular basis. The study was published this week in the journal Protein and Cell.
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wilson P Daugherty, MD, PH D 301 Riverview Ave Ste 202a, Norfolk, VA 23510-1065 Ph: (757) 252-9140 | Wilson P Daugherty, MD, PH D 301 Riverview Ave Ste 202a, Norfolk, VA 23510-1065 Ph: (757) 252-9140 |
News Archive
Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.
A team of researchers from the National University of Singapore's (NUS) Yong Loo Lin School of Medicine has demonstrated for the first time that hydrogen sulphide (H2S), when applied exogenously, could protect testicular germ cells, which are male reproductive cells, against heat-induced injury, which is one of the major causes of male infertility.
The proteins that have now been identified shouldn't actually exist. Nevertheless, they build the core of cellular aggregates whose identity has been enigmatic until now. These aggregates are typically associated with hereditary neurodegenerative diseases including variants of frontotemporal dementia (FTD), also known as frontotemporal lobar degeneration (FTLD), and amyotrophic lateral sclerosis (ALS). They are likely to be damaging and might be a target for therapy.
A team of Chinese researchers have for the first time "mended" defective embryos using chemical surgery to free them of a faulty gene that leads to beta thalassemia. Until now this defect was found to be incorrigible caused due to a single misspelling in the DNA code. Beta thalassemia is a dreaded blood disorder wherein the child is unable to make healthy blood needing blood transfusions on a regular basis. The study was published this week in the journal Protein and Cell.
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.
› Verified 2 days ago
Jodi Anderson Gehring, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 301 Riverview Ave Ste 202a, Norfolk, VA 23510 Phone: 757-252-9015 Fax: 757-510-9041 | |
Mr. Paul Bruce Mitchell Jr., MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 Riverview Ave Ste 202a, Norfolk, VA 23510 Phone: 757-252-9140 | |
Wylie H Zhu, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 Riverview Ave Ste 202a, Norfolk, VA 23510 Phone: 757-252-9140 Fax: 757-793-4149 | |
Mr. Ran Vijai Pratap Singh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 Riverview Ave Ste 202a, Norfolk, VA 23510 Phone: 757-252-9140 | |
Joseph Frank Dilustro, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Suite 5a, Norfolk, VA 23507 Phone: 757-668-7990 Fax: 757-668-7995 | |
Shannon Wang Clark, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 301 Riverview Ave Ste 202a, Norfolk, VA 23510 Phone: 757-252-9140 Fax: 757-793-4149 |